HW
AVNS

Hancock Whitney’s Avanos Medical AVNS Stock Holding History

Hancock Whitney’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-162,977
Closed -$11.2M – 812
2018
Q3 		$11.2M Buy
162,977
+120
+0.1% +$7.72K 0.32% 97
2018
Q2 		$9.32M Sell
162,857
-50,252
-24% -$2.66M 0.43% 100
2018
Q1 		$9.82M Sell
213,109
-16,078
-7% -$763K 0.44% 96
2017
Q4 		$10.6M Sell
229,187
-450
-0.2% -$20.7K 0.44% 101
2017
Q3 		$10.3M Buy
229,637
+16,292
+8% +$695K 0.44% 109
2017
Q2 		$8.38M Buy
213,345
+189
+0.1% +$7.14K 0.35% 131
2017
Q1 		$8.12M Sell
213,156
-140
-0.1% -$5.46K 0.34% 139
2016
Q4 		$7.89M Buy
213,296
+781
+0.4% +$27.9K 0.29% 141
2016
Q3 		$7.37M Buy
+212,515
New +$7.44M 0.29% 143

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hancock Whitney's AVNS Position: Q4 2018 in Review

Hancock Whitney sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 162,977 shares — an estimated $11.2M sold.

Hancock Whitney first reported a position in AVNS in Q3 2016 and held it in 9 quarters. The position peaked at $11.2M in Q3 2018. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • Hancock Whitney reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • Hancock Whitney sold 162,977 Avanos Medical shares in Q4 2018, an estimated $11.2M.
  • Hancock Whitney first reported a position in Avanos Medical in Q3 2016 and held it in 9 quarters.
  • Hancock Whitney's Avanos Medical position peaked at $11.2M in Q3 2018.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Hancock Whitney's 13F filing for Q4 2018, filed 15 Feb 2019.